Showing results (101-110 of 434) with videos related to
Sort By:
Pageof 44
Diabetes Technology & Therapeutics|December 24, 2010
Effectiveness of sitagliptin in asian Indian patients with type 2 diabetes-an Indian tertiary diabetes care center experienceChidambarann Sudhakaran, Utkal Kishore, Ranjit Mohan Anjana, et al.Perspectives in Clinical Research|April 18, 2014
Why are clinical trials necessary in India?Subramani Poongothai, Ranjit Unnikrishnan, Jeyakumar Balasubramanian, et al.Diabetes Technology & Therapeutics|May 4, 2012
Clinical profile and complications of childhood- and adolescent-onset type 2 diabetes seen at a diabetes center in south IndiaAnandakumar Amutha, Manjula Datta, Ranjit Unnikrishnan, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 8, 2014
Clinical profile of nonalcoholic Fatty liver disease among young patients with type 1 diabetes mellitus seen at a diabetes speciality center in IndiaRamanujam Vendhan, Anandakumar Amutha, Ranjit Mohan Anjana, et al.The International Journal of Behavioral Nutrition and Physical Activity|October 15, 2013
Physical activity patterns among South-Asian adults: a systematic reviewChathuranga D Ranasinghe, Priyanga Ranasinghe, Ranil Jayawardena, et al.The Indian Journal of Medical Research|August 14, 2009
Diet & insulin resistance: a review & Asian Indian perspectiveSumit Isharwal, Anoop Misra, J S Wasir, et al.Diabetes & Metabolic Syndrome|January 20, 2022
An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19Awadhesh Kumar Singh, Akriti Singh, Ritu Singh, et al.Diabetes & Metabolic Syndrome|November 6, 2021
Molnupiravir in COVID-19: A systematic review of literatureAwadhesh Kumar Singh, Akriti Singh, Ritu Singh, et al.Diabetes & Metabolic Syndrome|September 15, 2022
Once-weekly basal insulin icodec: Looking ONWARDS from pharmacology to clinical trialsAwadhesh Kumar Singh, Akriti Singh, Ritu Singh, et al.Diabetes & Metabolic Syndrome|May 8, 2024
Efficacy and safety of oral semaglutide in type 2 diabetes: A systematic review of real-world evidenceAwadhesh Kumar Singh, Ritu Singh, Akriti Singh, et al.Pageof 44